Metropolitan Life Insurance Company (MetLife)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-11,128
| Closed | -$1.08M | – | 2597 |
|
|
2019
Q3 | $1.08M | Buy |
11,128
+729
| +7% | +$70.7K | 0.02% | 817 |
|
|
2019
Q2 | $1.06M | Buy |
10,399
+192
| +2% | +$19.7K | 0.02% | 860 |
|
|
2019
Q1 | $1.16M | Hold |
10,207
| – | – | 0.02% | 807 |
|
|
2018
Q4 | $400K | Hold |
10,207
| – | – | 0.01% | 1342 |
|
|
2018
Q3 | $557K | Hold |
10,207
| – | – | 0.01% | 1283 |
|
|
2018
Q2 | $845K | Buy |
10,207
+1,180
| +13% | +$97.7K | 0.01% | 1005 |
|
|
2018
Q1 | $601K | Buy |
9,027
+202
| +2% | +$13.5K | 0.01% | 1159 |
|
|
2017
Q4 | $454K | Sell |
8,825
-9,415
| -52% | -$484K | 0.01% | 1355 |
|
|
2017
Q3 | $1.63M | Buy |
18,240
+2,299
| +14% | +$205K | 0.01% | 1014 |
|
|
2017
Q2 | $952K | Buy |
15,941
+2,093
| +15% | +$125K | 0.01% | 1268 |
|
|
2017
Q1 | $739K | Hold |
13,848
| – | – | 0.01% | 1399 |
|
|
2016
Q4 | $691K | Hold |
13,848
| – | – | 0.01% | 1538 |
|
|
2016
Q3 | $832K | Buy |
13,848
+1,070
| +8% | +$64.3K | 0.01% | 1387 |
|
|
2016
Q2 | $653K | Buy |
12,778
+4,955
| +63% | +$253K | ﹤0.01% | 1530 |
|
|
2016
Q1 | $231K | Buy |
7,823
+2,465
| +46% | +$72.8K | ﹤0.01% | 2088 |
|
|
2015
Q4 | $243K | Hold |
5,358
| – | – | ﹤0.01% | 2108 |
|
|
2015
Q3 | $224K | Sell |
5,358
-1,719
| -24% | -$71.9K | ﹤0.01% | 2213 |
|
|
2015
Q2 | $427K | Buy |
+7,077
| New | +$427K | ﹤0.01% | 1852 |
|